To some, cannabis and exercise may seem like an unlikely pairing. But those in the know understand that cannabis in its various forms can serve as a great pre, during, or post-workout supplement. These Top 5 insights from BDS Analytics counter the “lazy stoner” stereotype and show that cannabis often is a welcome addition to Consumers’ workout routines.
The latest Cannabis Intelligence Briefing from Arcview Market Research and BDS Analytics: CBD: Cannabidiol Escapes the Dispensary details CBD’s move from legal cannabis dispensaries to the general retail market. At present, the bulk (65%) of the $1.9 billion in annual spending on CBD products in the U.S. takes place through licensed dispensaries in legal cannabis states.
As cannabis products and delivery systems continue to evolve, infused beverages are rapidly moving to the forefront– most recently marked by the announced partnership between Arizona Beverages and Dixie Brands. As of September 1, 2019, BDS Analytics market data reports 107 beverage brands in the legal dispensary channel (up from 69 in Q2 of 2018) across CA, CO, OR, AZ, and NV and BDS Analytics predicts beverage sales in the regulated dispensary channel to reach $1 billion by 2022. Here are the Top 5 canna-beverage facts from BDS Analytics:
How many products contain cannabis? Hundreds. Flower – of course – and pre-rolls. Vape pens and concentrates like shatter and Live Resin. Creams and massage oils. Chocolate chip cookies, coffee sodas, pills, strawberry taffy, powders for adding to hot tea or cold juice. Companies are rolling out myriad new products in pot-friendly states every week — it’s remarkable.
Cannabis Ingestibles cover a lot of ground, including everything from pills to slices of pie to bottles of THC-infused cold-brewed coffee. But one style of ingestible dominates the market: the gummy.
As more U.S. states move towards legalization, cannabis consumers are taking advantage of the unique opportunity to address medical needs through the available products at their local dispensaries. Though medical cannabis is generally not covered by most U.S. insurance plans, trends indicate increased use of cannabis as an alternative to more traditional forms of medication. Here are BDS Analytics' Top 5 Insights into the impact of legal cannabis sales on the over-the-counter (OTC) and prescription drug channels:
The holiday always stokes robust sales. But this year’s 4/20? It’s gonna be big.
By the time it drew to a close, California’s first year of legal adult-use cannabis had matured into an industry behemoth.
The worldwide legal cannabis industry saw massive changes in 2018, as detailed in the 2019 Update to “The State of Legal Marijuana Markets, 6th Edition” (SOLMM6), published January 15, 2019. We had in that original report forecast the market to hit $12.9 billion; but, in the final reckoning of the year, re-estimated spending to only reach $12.2 billion. Worldwide spending is now forecast to grow 39% to $17 billion in 2019, and to reach $31.6 billion in 2022 – an average compound annual growth rate (CAGR) of 26% from 2017-2022.
When Colorado kicked-off legal adult-use cannabis sales in the United States in 2014, unbranded flower fully dominated the marketplace, capturing more than 60 percent of all sales. Concentrates, edibles and topicals were far behind.